FDA, COVID-19 and vaccine
Digest more
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The US Food and Drug Administration (FDA) is set to restrict the Covid-19 booster doses to older adults and those at risk of severe illness.
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.